Historical data shows that a consistent $500 monthly investment into BioRestorative Therapies, Inc. (BRTX) starting in 2020 would have turned a total investment of $49K into $11K today. This represents a total return of -77.5% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
BioRestorative Therapies, Inc. does not currently pay a notable dividend. For growth-focused stocks like BRTX, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $11K without the need for dividend reinvestment.
BRTX vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,BRTX underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $87K, compared to BRTX's $11K.